1. Home
  2. SRRK vs MCY Comparison

SRRK vs MCY Comparison

Compare SRRK & MCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

N/A

Current Price

$53.87

Market Cap

6.8B

Sector

Health Care

ML Signal

N/A

Logo Mercury General Corporation

MCY

Mercury General Corporation

N/A

Current Price

$103.62

Market Cap

5.7B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SRRK
MCY
Founded
2012
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
5.7B
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
SRRK
MCY
Price
$53.87
$103.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
1
Target Price
$56.17
$100.00
AVG Volume (30 Days)
1.0M
207.5K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
1.33%
EPS Growth
N/A
15.62
EPS
N/A
8.20
Revenue
N/A
$5,992,468,000.00
Revenue This Year
N/A
$5.16
Revenue Next Year
$534.24
$5.59
P/E Ratio
N/A
$12.48
Revenue Growth
N/A
9.44
52 Week Low
$27.07
$74.29
52 Week High
$61.76
$113.06

Technical Indicators

Market Signals
Indicator
SRRK
MCY
Relative Strength Index (RSI) 52.26 48.54
Support Level $44.26 $100.26
Resistance Level $58.49 $103.86
Average True Range (ATR) 2.35 2.51
MACD -0.38 -0.00
Stochastic Oscillator 23.61 52.42

Price Performance

Historical Comparison
SRRK
MCY

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About MCY Mercury General Corporation

Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The company offers the following types of automobile coverage: collision, property damage, bodily injury (BI), comprehensive, personal injury protection (PIP), underinsured and uninsured motorist, and other hazards. Additionally, it offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages. The company has one reportable business segment, the Property and Casualty business segment.

Share on Social Networks: